Skip to main content
. 2012 Oct 22;4(2):182–189. doi: 10.1111/jdi.12000

Table 1. Demographics and baseline characteristics.

Japan ITT patients (n = 155) Japan extension study patients
EBID→EQW EQW
(n = 62) (n = 74)
Age (years) 61 (9) 60 (9) 61 (10)
Male, n (%) 91 (59) 38 (61) 43 (58)
HbA1c (%) 8.8 (0.9) 8.8 (1.0) 8.8 (1.0)
Duration of diabetes (years) 10 (7) 11 (7) 10 (6)
FSG (mg/dL) 166 (41) 168 (41) 167 (43)
Bodyweight (kg) 69 (13) 71 (13) 68 (13)
BMI (kg/m2) 26 (4) 27 (4) 26 (3)
Background OAM, n (%)
SU 35 (23) 11 (18) 19 (26)
SU + MET 79 (51) 34 (55) 37 (50)
SU + TZD 18 (12) 10 (16) 6 (8)
MET 19 (12) 6 (10) 10 (14)
MET + TZD 2 (1) 0 (0) 1 (1)
TZD 2 (1) 1 (2) 1 (1)

Data are presented as mean (standard deviation), unless otherwise noted. BMI, body mass index; EBID, exenatide twice daily; EQW, exenatide once weekly; FSG, fasting serum glucose; HbA1c, glycated hemoglobin; ITT, intent‐to‐treat; MET, metformin; OAM, oral antidiabetes medication; SU, sulfonylurea; TZD, thiazolidinedione.